310 related articles for article (PubMed ID: 7931568)
1. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs.
Hooks MS; Juncos JL; Justice JB; Meiergerd SM; Povlock SL; Schenk JO; Kalivas PW
J Neurosci; 1994 Oct; 14(10):6144-52. PubMed ID: 7931568
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
[TBL] [Abstract][Full Text] [Related]
3. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
[TBL] [Abstract][Full Text] [Related]
4. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
Wong AC; Shetreat ME; Clarke JO; Rayport S
Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
[TBL] [Abstract][Full Text] [Related]
5. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat.
Jansson A; Goldstein M; Tinner B; Zoli M; Meador-Woodruff JH; Lew JY; Levey AI; Watson S; Agnati LF; Fuxe K
Neuroscience; 1999 Mar; 89(2):473-89. PubMed ID: 10077329
[TBL] [Abstract][Full Text] [Related]
6. Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors.
Tarazi FI; Campbell A; Yeghiayan SK; Baldessarini RJ
Neuroscience; 1998 Mar; 83(1):169-76. PubMed ID: 9466407
[TBL] [Abstract][Full Text] [Related]
7. Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.
Claye LH; Akunne HC; Davis MD; DeMattos S; Soliman KF
Mol Neurobiol; 1995; 11(1-3):55-66. PubMed ID: 8561968
[TBL] [Abstract][Full Text] [Related]
8. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
Thomas WS; Neal-Beliveau BS; Joyce JN
Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
[TBL] [Abstract][Full Text] [Related]
9. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
David HN; Abraini JH
Eur J Neurosci; 2001 Jun; 13(11):2157-64. PubMed ID: 11422457
[TBL] [Abstract][Full Text] [Related]
10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
11. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion.
Neisewander JL; O'Dell LE; Redmond JC
Brain Res; 1995 Feb; 671(2):201-12. PubMed ID: 7743209
[TBL] [Abstract][Full Text] [Related]
12. Cocaine-induced mu opioid receptor occupancy within the striatum is mediated by dopamine D2 receptors.
Soderman AR; Unterwald EM
Brain Res; 2009 Nov; 1296():63-71. PubMed ID: 19699185
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
[TBL] [Abstract][Full Text] [Related]
15. Enhanced amphetamine sensitivity and increased expression of dopamine D2 receptors in postpubertal rats after neonatal excitotoxic lesions of the medial prefrontal cortex.
Flores G; Wood GK; Liang JJ; Quirion R; Srivastava LK
J Neurosci; 1996 Nov; 16(22):7366-75. PubMed ID: 8929443
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
17. Repeated treatment with the selective kappa opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors.
Izenwasser S; Acri JB; Kunko PM; Shippenberg T
Synapse; 1998 Nov; 30(3):275-83. PubMed ID: 9776131
[TBL] [Abstract][Full Text] [Related]
18. Effects of prefrontal cortical lesions on neuropeptide and dopamine receptor gene expression in the striatum-accumbens complex.
Baca SM; Lipska BK; Egan MF; Bachus SE; Ferguson JN; Hyde TM
Brain Res; 1998 Jun; 797(1):55-64. PubMed ID: 9630515
[TBL] [Abstract][Full Text] [Related]
19. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
[TBL] [Abstract][Full Text] [Related]
20. Preferential vulnerability of nucleus accumbens dopamine binding sites to low-level lead exposure: time course of effects and interactions with chronic dopamine agonist treatments.
Pokora MJ; Richfield EK; Cory-Slechta DA
J Neurochem; 1996 Oct; 67(4):1540-50. PubMed ID: 8858938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
